Quantum eMotion’s Strategic Pivot: Navigating the Path to a U.S. Listing

Quantum eMotion CA74767K1030

For Quantum eMotion, a pivotal strategic objective is now in focus: securing a listing on a major U.S. exchange. The company took a formal step toward this goal in late January by filing a Form 40-F registration statement with the U.S. Securities and Exchange Commission (SEC), targeting a listing on the NYSE American. This move places the company in a critical transition period where investor attention is fixed on one central issue: whether the uplisting can be achieved without triggering significant stock price volatility or new capital market disruptions.

The listing process is now contingent upon a dual regulatory approval. The SEC must declare the Form 40-F effective, and Quantum eMotion must simultaneously satisfy all specific listing requirements set by the NYSE American. During this interim phase, the market is closely monitoring the company's ability to maintain typical minimum standards, such as its share price and market capitalization, as such procedures are often accompanied by heightened volatility.

A Solid Financial Foundation for Growth

Management points to a robust liquidity position as the foundation for its next phase. According to its latest quarterly report (Q3 2025), Quantum eMotion held cash and equivalents of approximately $24.7 million. This financial cushion is intended to fund two parallel initiatives: increased research and development expenditures and the establishment of a tangible commercial presence in the United States.

A planned U.S. subsidiary is central to this strategy. It is designed to facilitate direct collaboration with partners in key sectors such as financial services, healthcare, and defense.

Commercial Progress and Sector Partnerships

Alongside its capital market ambitions, the company is advancing its commercial roadmap. By the end of 2025, Quantum eMotion highlighted several operational milestones that inform its current valuation perspective:

• Energy Sector Deployment: The launch of the "Tough Bhoy" energy storage system with partners. This initiative integrates the company's security technology for deployment in extreme environments, including arctic regions and remote defense installations.
• Healthcare Expansion: A partnership involving Greybox Solutions aims to deploy reimbursable platforms for treating chronically ill patients. These platforms feature "quantum-safe" cybersecurity to protect sensitive patient data.
• Growing Market Recognition: The company was recently highlighted as a notable holding within the Defiance Quantum ETF, underscoring broader investment interest in the theme of quantum-resistant encryption.

At its operational core, the commercialization of its patented Quantum Random Number Generator (QRNG) technology remains a key driver. Investors are likely to watch for the translation of these partnerships into measurable revenue streams, particularly within fields like cybersecurity and critical infrastructure.

Looking ahead, the market anticipates several key developments: regulatory feedback on the NYSE American application, further updates on the establishment of the U.S. subsidiary, and announcements of new commercial agreements.